Concepedia

Lena Lapkina-Gendler

LL

Statistics

Publications

6

Citations

164

H-Index

6

Active since

2016

Affiliations

Schneider Children's Medical Center(Current)

Tel Aviv University

New York University

Lena Lapkina-Gendler is an author at Schneider Children's Medical Center specializing in molecular oncology, cancer genomics, and insulin-like growth factor-1.

Publications per year

2016–2021

6

Publications

6

Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action

Karthik Nagaraj, Lena Lapkina-Gendler, Rive Sarfstein et al. · Proceedings of the National Academy of Sciences · 2018 · 62 citations · Full text

, , +17

Identification of signaling pathways associated with cancer protection in Laron syndrome

Lena Lapkina-Gendler, Itai Rotem, Metsada Pasmanik‐Chor et al. · Endocrine Related Cancer · 2016 · 37 citations · Full text

, , +15

The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway

Rand Shibel, Rive Sarfstein, Karthik Nagaraj et al. · Cells · 2021 · 30 citations · Full text

, , +17

Fifty years on: New lessons from Laron syndrome.

Haim Werner, Lena Lapkina-Gendler, Zvi Laron · PubMed · 2017 · 13 citations

, , +3

Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer

Laris Achlaug, Rive Sarfstein, Karthik Nagaraj et al. · Oncotarget · 2019 · 11 citations · Full text

, , +17

1–5 of 6